Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Dermatop Basecreme is the vehicle (base) cream formulation for the Dermatop product line, which typically contains the active pharmaceutical ingredient prednicarbate, a nonhalogenated corticosteroid. As a standalone product, Dermatop Basecreme does not contain an active pharmaceutical ingredient and is primarily used as an emollient or as a placebo/comparator in clinical research. In a Phase 2 imaging study conducted by the Technical University Dresden, it was utilized as a comparator to assess epidermal and dermal thickness changes in patients with atopic dermatitis using optical coherence tomography (OCT) and 20-MHz ultrasound. It is designed to provide skin hydration and barrier support while being chemically compatible with prednicarbate.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Dermatop Basecreme.